Robert G Price

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Top Venues

ERJ open research

Pharmaceutical statistics

The European respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ian D Pavord, Roland Buhl, Monica Kraft, Charlene M Prazma, Robert G Price, Peter J Howarth, Steven W Yancey
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab. ERJ open research 8 (2) (2022)
Mark C Liu, Elisabeth H Bel, Oliver Kornmann, Wendy C Moore, Norihiro Kaneko, Steven G Smith, Neil Martin, Robert G Price, Steven W Yancey, Marc Humbert
Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET. ERJ open research 8 (1) (2022)
Nicky Best, Robert G Price, Isabelle J Pouliquen, Oliver N Keene
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing. Pharmaceutical statistics 20 (3) (2021)
Wendy C Moore, Oliver Kornmann, Marc Humbert, Claude Poirier, Elisabeth H Bel, Norihiro Kaneko, Steven G Smith, Neil Martin, Martyn J Gilson, Robert G Price, Eric S Bradford, Mark C Liu
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study). The European respiratory journal (2021)